Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the
                    <scp>KEYNOTE</scp>
                    ‐158 and
                    <scp>KEYNOTE</scp>
                    ‐028 studies

A. Piha‐Paul, Sarina; Oh, Do‐Youn; Ueno, Makoto; Malka, David; Cheol Chung, Hyun; Nagrial, Adnan; K. Kelley, Robin; Ros, Willeke; Italiano, Antoine; Nakagawa, Kazuhiko; S. Rugo, Hope; de Braud, Filippo; Iolanda Varga, Andrea; Hansen, Aaron; Wang, Hui; Krishnan, Suba; G. Norwood, Kevin; Doi, Toshihiko

doi:10.1002/ijc.33013

Public

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies

Shared by NobleBlocks on May 2, 2020 • 12:00 AM UTC

Authors:

Sarina A. Piha‐Paul

Do‐Youn Oh

Makoto Ueno

Abstract

Abstract We present data from patients with advanced biliary tract cancer (BTC) receiving pembrolizumab in the KEYNOTE‐158 (NCT02628067; phase 2) and KEYNOTE‐028 (NCT02054806; phase 1b) studies. Eligible patients aged ≥18 years from both studies had histologically/cytologically confirmed incurable B...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!